Skip to main content
OpenTrials

Clinical trial condition

Prostate Adenocarcinoma Plus > 50% Immunohistochemical Staining for Neuroendocrine Markers

Explore clinical trials studying Prostate Adenocarcinoma Plus > 50% Immunohistochemical Staining for Neuroendocrine Markers. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

Prostate Adenocarcinoma Plus > 50% Immunohistochemical Staining for Neuroendocrine Markers trial results

Completed

A Phase II Trial of MLN8237 in Patients With Metastatic Castrate Resistant and Neuroendocrine Prostate Cancer

NCT01799278

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +10 more
Locations
  • University of Chicago Chicago, Illinois, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
View Trial Details

Related conditions